COBAS AMPLICOR CT/NG TEST 20759414122

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2011-03-08 for COBAS AMPLICOR CT/NG TEST 20759414122 manufactured by Roche Molecular Systems.

Event Text Entries

[8984301] Corrected data: date of report, date received by manufacturer, follow-up report 1, additional information, device evaluated by manufacture: no (the patient sample, kit batch, and customer data were not provided), (b)(4): analysis of labeling performed. (b)(4): device performed according to specifications. (b)(4): unable to confirm complaint, device operated according to specifications, device not returned. Despite repeated attempts, sufficient information was not provided by the customer to perform a more in-depth investigation. The date of report was set based on the last day the complaint case was open, which signified the final point where no new / additional information would be provided. Based on the available, minimal information, the investigation showed no evidence of a product non-conformance. The sample in question was not available from the customer for investigative testing. The issue of (b)(6) results with the cobas amplicor test is plausible and may be within method manual claims, however no information was provided such as (b)(6) or number of samples tested to determine if the results were within claims. The sensitivity / specificity rates, outlined in the method manual, are on average between 91. 7-93. 1% for sensitivity and 94. 7 -97. 9% for specificity. These rates are dependent on sex and whether an internal control was used. Furthermore, it is unknown if the sample was truly (b)(6) infection. Based on the test results provided, initial result (b)(6) followed by duplicate repeat testing that yielded two (b)(6) results, this issue appears to be associated with a (b)(6) result. However, without further clarification from the customer, or the patient specimen, this hypothesis cannot be confirmed. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[16734160] A customer site in united states reported that they received discrepant (b)(6) results when using the cobas amplicor ct/ng test. The customer site protocol is to repeat test all (b)(6) results in duplicate, which is an off-label practice. As per product labeling, a valid result should be reported. Roche does not recommend or support the repeating of valid (b)(6) results for the assay. The customer site has been reporting out the repeat results when they are in agreement with the initial result. The original result was (b)(6) and the both repeat results were (b)(6). It is unknown which result was reported.
Patient Sequence No: 1, Text Type: D, B5


[17015413] A definitive conclusion cannot be drawn at this time, as the investigation into this issue is ongoing. The outcome of this investigation will be communicated through a follow-up report. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2011-00011
MDR Report Key2010827
Report Source05
Date Received2011-03-08
Date of Report2011-05-12
Date of Event2011-02-16
Date Mfgr Received2011-05-12
Device Manufacturer Date2011-02-16
Date Added to Maude2012-05-08
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202S
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS AMPLICOR CT/NG TEST
Generic NameDNA PROBE, NUCLEIC ACID AMPLIFICATION, CHLAMYDIA
Product CodeMKZ
Date Received2011-03-08
Catalog Number20759414122
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HW 202S BRANCHBURG NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2011-03-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.